317 related articles for article (PubMed ID: 35210321)
1. Asthma management in low and middle income countries: case for change.
Mortimer K; Reddel HK; Pitrez PM; Bateman ED
Eur Respir J; 2022 Sep; 60(3):. PubMed ID: 35210321
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
3. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
4. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
Janjua S; Schmidt S; Ferrer M; Cates CJ
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
[TBL] [Abstract][Full Text] [Related]
5. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
Cloutier MM; Dixon AE; Krishnan JA; Lemanske RF; Pace W; Schatz M
JAMA; 2020 Dec; 324(22):2301-2317. PubMed ID: 33270095
[TBL] [Abstract][Full Text] [Related]
6. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
[TBL] [Abstract][Full Text] [Related]
7. "As-Needed" Inhaled Corticosteroids for Patients With Asthma.
Cardet JC; Papi A; Reddel HK
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):726-734. PubMed ID: 36702246
[TBL] [Abstract][Full Text] [Related]
8. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries.
Jayasooriya S; Stolbrink M; Khoo EM; Sunte IT; Awuru JI; Cohen M; Lam DC; Spanevello A; Visca D; Centis R; Migliori GB; Ayuk AC; Buendia JA; Awokola BI; Del-Rio-Navarro BE; Muteti-Fana S; Lao-Araya M; Chiarella P; Badellino H; Somwe SW; Anand MP; Garcí-Corzo JR; Bekele A; Soto-Martinez ME; Ngahane BHM; Florin M; Voyi K; Tabbah K; Bakki B; Alexander A; Garba BL; Salvador EM; Fischer GB; Falade AG; ŽivkoviĆ Z; Romero-Tapia SJ; Erhabor GE; Zar H; Gemicioglu B; Brandão HV; Kurhasani X; El-Sharif N; Singh V; Ranasinghe JC; Kudagammana ST; Masjedi MR; Velásquez JN; Jain A; Cherrez-Ojeda I; Valdeavellano LFM; Gómez RM; Mesonjesi E; Morfin-Maciel BM; Ndikum AE; Mukiibi GB; Reddy BK; Yusuf O; Taright-Mahi S; Mérida-Palacio JV; Kabra SK; Nkhama E; Filho NR; Zhjegi VB; Mortimer K; Rylance S; Masekela RR
Int J Tuberc Lung Dis; 2023 Sep; 27(9):658-667. PubMed ID: 37608484
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
[TBL] [Abstract][Full Text] [Related]
10. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
11. The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem.
Kaplan A
Adv Ther; 2021 Mar; 38(3):1369-1381. PubMed ID: 33474708
[TBL] [Abstract][Full Text] [Related]
12. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
Respirology; 2022 Jan; 27(1):14-35. PubMed ID: 34668278
[TBL] [Abstract][Full Text] [Related]
13. It is time to change the way we manage mild asthma: an update in GINA 2019.
Muneswarao J; Hassali MA; Ibrahim B; Saini B; Ali IAH; Verma AK
Respir Res; 2019 Aug; 20(1):183. PubMed ID: 31412856
[TBL] [Abstract][Full Text] [Related]
14. Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction-Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA.
Ozseker ZF; Aksu K; Mutlu LC; Mutlu P; Ozturk C;
Curr Allergy Asthma Rep; 2022 Oct; 22(10):123-134. PubMed ID: 35689764
[TBL] [Abstract][Full Text] [Related]
15. The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription.
Domingo C; Singh D
Adv Ther; 2023 Apr; 40(4):1301-1316. PubMed ID: 36715896
[TBL] [Abstract][Full Text] [Related]
16. Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma.
Bigoni T; Alfano F; Baraldi F; Contoli M; Papi A
Expert Rev Respir Med; 2023; 17(8):623-634. PubMed ID: 37578053
[TBL] [Abstract][Full Text] [Related]
17. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
[TBL] [Abstract][Full Text] [Related]
18. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
FitzGerald JM; Arnetorp S; Smare C; Gibson D; Coulton K; Hounsell K; Golam S; Sadatsafavi M
Respir Med; 2020 Sep; 171():106079. PubMed ID: 32917353
[TBL] [Abstract][Full Text] [Related]
20. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TSC
BMJ Evid Based Med; 2022 Jun; 27(3):178-184. PubMed ID: 34282031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
